|
Volumn 26, Issue 12, 2007, Pages 1369-1372
|
Efficacy of thalidomide combined dexamethasone on newly diagnosed multiple myeloma
a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINEOPLASTIC AGENT;
CYTARABINE;
DEXAMETHASONE;
THALIDOMIDE;
VAD REGIMEN;
VINCRISTINE;
ADULT;
AGED;
ARTICLE;
CHEMICALLY INDUCED DISORDER;
CLINICAL TRIAL;
COMPARATIVE STUDY;
CONSTIPATION;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DISEASE FREE SURVIVAL;
FATIGUE;
FOLLOW UP;
HUMAN;
LEUKOPENIA;
MIDDLE AGED;
MULTIPLE MYELOMA;
PATHOLOGY;
REMISSION;
SURVIVAL RATE;
THROMBOCYTOPENIA;
ADULT;
AGED;
AGED, 80 AND OVER;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
CONSTIPATION;
CYTARABINE;
DEXAMETHASONE;
DISEASE-FREE SURVIVAL;
FATIGUE;
FOLLOW-UP STUDIES;
HUMANS;
LEUKOPENIA;
MIDDLE AGED;
MULTIPLE MYELOMA;
REMISSION INDUCTION;
SURVIVAL RATE;
THALIDOMIDE;
THROMBOCYTOPENIA;
VINCRISTINE;
|
EID: 73349096935
PISSN: 1000467X
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (2)
|
References (0)
|